A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects

Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.749
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Lamotrigine Does Not Prolong QTc in a Thorough QT/QTc Study in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2008English

Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2016English

A Randomized Single-Dose Safety, Pharmacokinetics, Food Effect and Effect on Thorough QT/QTc of Chinfloxacin in Healthy Chinese Volunteers

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Effects of Subcutaneous Pasireotide on Cardiac Repolarization in Healthy Volunteers: A Single-Center, Phase I, Randomized, Four-Way Crossover Study

Journal of Clinical Pharmacology
Pharmacology
2013English

Fractionated Repolarization Induced by Sotalol in Healthy Subjects

2005English

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2019English

Ectopic Expression of KCNE3 Accelerates Cardiac Repolarization and Abbreviates the QT Interval

Journal of Clinical Investigation
Medicine
2002English

The Sodium Glucose Cotransporter 2 Inhibitor Empagliflozin Does Not Prolong QT Interval in a Thorough QT (TQT) Study

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Single Therapeutic and Supratherapeutic Doses of Sacubitril/Valsartan (LCZ696) Do Not Affect Cardiac Repolarization

European Journal of Clinical Pharmacology
MedicinePharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy